International audienceMicrosatellite instability (MSI)1 is characterized by the accumulation of mutations (insertions or deletions of several nucleotides) in microsatellites, caused by DNA mismatch repair system deficiency. Approximately 15% to 20% of colorectal cancers (CRCs) present with MSI, the origin of which can be sporadic or owing to genetic predisposition to Lynch syndrome/hereditary nonpolyposis CRC or constitutional mismatch repair deficiency syndrome. The MSI phenotype is associated with a better survival rate for patients with stage II/III CRC and isalso a major predictive biomarker for the efficacy of immune checkpoint blockade therapy in metastatic CRC. The gold standard method for MSI detection includes standard PCR followed...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
International audienceEvery colorectal cancer (CRC) patient should be tested for microsatellite inst...
A significant proportion (∼15%) of colorectal cancer (CRC), either sporadic or arising in the settin...
Microsatellites are short tandem repeat DNA sequences of one to tetra base pairs distributed through...
Detection of microsatellite instability (MSI) is the standard part of mutational analysis in heredit...
<p>Microsatellite Instability Testing in CRC and Interpretation</p> <p>Microsatellite instability is...
Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Microsatellite instability (MS...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
After introduction of the Bethesda microsatellite test panel demonstration of microsatellite instabi...
Microsatellite instability (MSI) is a molecular hallmark for some colorectal cancers (CRCs) in which...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
Abstract Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary n...
Microsatellite instability (MSI) is a molecular hallmark for some colorectal cancers (CRCs) in which...
IF 5.65International audienceBackground Every colorectal cancer (CRC) patient should be tested for m...
Microsatellite instability (MSI) is a genomic alteration in which microsatellites, usually of one to...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
International audienceEvery colorectal cancer (CRC) patient should be tested for microsatellite inst...
A significant proportion (∼15%) of colorectal cancer (CRC), either sporadic or arising in the settin...
Microsatellites are short tandem repeat DNA sequences of one to tetra base pairs distributed through...
Detection of microsatellite instability (MSI) is the standard part of mutational analysis in heredit...
<p>Microsatellite Instability Testing in CRC and Interpretation</p> <p>Microsatellite instability is...
Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Microsatellite instability (MS...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
After introduction of the Bethesda microsatellite test panel demonstration of microsatellite instabi...
Microsatellite instability (MSI) is a molecular hallmark for some colorectal cancers (CRCs) in which...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
Abstract Tumour microsatellite instability (MSI) is useful in identifying patients with hereditary n...
Microsatellite instability (MSI) is a molecular hallmark for some colorectal cancers (CRCs) in which...
IF 5.65International audienceBackground Every colorectal cancer (CRC) patient should be tested for m...
Microsatellite instability (MSI) is a genomic alteration in which microsatellites, usually of one to...
Microsatellite instability (MSI) results from defective DNA produced as an end result of mismatch. A...
International audienceEvery colorectal cancer (CRC) patient should be tested for microsatellite inst...
A significant proportion (∼15%) of colorectal cancer (CRC), either sporadic or arising in the settin...